The Effects of the Female Hormones on Cerebral Perfusion

Recruiting Observational Study
Cerebral Perfusion Contraception Menstrual Cycle
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 25
Sex
Female
Study type
Observational
Participants needed
62 (estimated)
Sponsor
University Ghent · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Measuring brain perfusion is biased by a inter- and intrasubject variability, caused by physiological and lifestyle factors. In this study, the investigators want to investigate the variations in cerebral perfusion and other brain parameters (grey matter, resting-state brain activity, brain connectivity and white matter diffusion) caused by the female sex hormones and hormonal contraception.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Bachelor or Master student * Minimum of 3 months not using contraception of using Deso20 Exclusion Criteria: * No informed consent * MRI-contraindications * Claustrophobia * Pregnancy or breastfeeding * Chronic diseases and chronic medication use * Smoker * Drug use * Abuse …
Contacts

Patricia Clement, Msc

9 332 1330

patricia.clement@ugent.be

CONTACT